Clinical Evidence
254 results
HDx therapy enabled by Theranova
The Rationale for Expanded Hemodialysis Therapy (HDx)
HDx therapy enabled by Theranova
The real-life study on expanded hemodialysis (HDx): 9 months experience of a single hemodialysis unit
HDx therapy enabled by Theranova
The use of medium cutoff dialyzers in patients with multiple myeloma and acute kidney injury requiring hemodialysis: A systematic review
HDx therapy enabled by Theranova
Theranova versus FX80: The impact on anemia management in hemodialysis.
PD
Trends in outcomes for an automated peritoneal dialysis program with and without remote management in Columbia - Sanabria M, et al.
HDx therapy enabled by Theranova
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration
HDx therapy enabled by Theranova
UK Clinical Experiences of a New Expanded Hemodialysis Therapy with a Novel Medium Cut-Off Dialyzer
HDx therapy enabled by Theranova
Updates on hemodialysis techniques with a common denominator: The personalization of the dialytic therapy.
HDx therapy enabled by Theranova
Uremia Retention Molecules and Clinical Outcomes
HDx therapy enabled by Theranova
Use of regional citrate anticoagulation with medium cut-off membrane: pilot report
HDx therapy enabled by Theranova
Water saving comparison at different dialysate flows in expanded hemodialysis
Vantive is a trademark of Vantive Health LLC or its affiliates.